Raia Drogasil S.A (RADL3) - Total Assets

Latest as of December 2025: R$25.47 Billion BRL ≈ $5.00 Billion USD

Based on the latest financial reports, Raia Drogasil S.A (RADL3) holds total assets worth R$25.47 Billion BRL (≈ $5.00 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Raia Drogasil S.A's book value for net asset value and shareholders' equity analysis.

Raia Drogasil S.A - Total Assets Trend (2000–2025)

This chart illustrates how Raia Drogasil S.A's total assets have evolved over time, based on quarterly financial data.

Raia Drogasil S.A - Asset Composition Analysis

Current Asset Composition (December 2025)

Raia Drogasil S.A's total assets of R$25.47 Billion consist of 58.5% current assets and 41.5% non-current assets.

Asset Category Amount (BRL) % of Total Assets
Cash & Equivalents R$0.00 2.0%
Accounts Receivable R$4.68 Billion 18.4%
Inventory R$9.58 Billion 37.6%
Property, Plant & Equipment R$0.00 0.0%
Intangible Assets R$964.95 Million 3.8%
Goodwill R$1.09 Billion 4.3%

Asset Composition Trend (2000–2025)

This chart illustrates how Raia Drogasil S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Raia Drogasil S.A (RADL3) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Raia Drogasil S.A's current assets represent 58.5% of total assets in 2025, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, down from 6.8% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 37.6% of total assets.

Raia Drogasil S.A Competitors by Total Assets

Key competitors of Raia Drogasil S.A based on total assets are shown below.

Company Country Total Assets
Yifeng Pharmacy
SHG:603939
China CN¥26.07 Billion
Empreendimentos Pague Menos S.A
SA:PGMN3
Brazil R$9.27 Billion
d1000 Varejo Farma Participações S.A
SA:DMVF3
Brazil R$1.93 Billion
High Tide Inc
V:HITI
Canada CA$346.42 Million
Laobaixing Pharmacy
SHG:603883
China CN¥20.34 Billion
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
China CN¥5.26 Billion
Yunnan Hongxiang Yixintang
SHE:002727
China CN¥15.84 Billion
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
China CN¥9.84 Billion

Raia Drogasil S.A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.46 1.38 1.54
Quick Ratio 0.52 0.47 0.59
Cash Ratio 0.00 0.04 0.00
Working Capital R$4.71 Billion R$3.48 Billion R$2.57 Billion

Raia Drogasil S.A - Advanced Valuation Insights

This section examines the relationship between Raia Drogasil S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.32
Latest Market Cap to Assets Ratio 0.30
Asset Growth Rate (YoY) 15.0%
Total Assets R$25.47 Billion
Market Capitalization $7.53 Billion USD

Valuation Analysis

Below Book Valuation: The market values Raia Drogasil S.A's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Raia Drogasil S.A's assets grew by 15.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Raia Drogasil S.A (2000–2025)

The table below shows the annual total assets of Raia Drogasil S.A from 2000 to 2025.

Year Total Assets Change
2025-12-31 R$25.47 Billion
≈ $5.00 Billion
+15.05%
2024-12-31 R$22.14 Billion
≈ $4.34 Billion
+10.19%
2023-12-31 R$20.09 Billion
≈ $3.94 Billion
+16.93%
2022-12-31 R$17.19 Billion
≈ $3.37 Billion
+16.31%
2021-12-31 R$14.78 Billion
≈ $2.90 Billion
+6.85%
2020-12-31 R$13.83 Billion
≈ $2.71 Billion
+12.90%
2019-12-31 R$12.25 Billion
≈ $2.40 Billion
+66.60%
2018-12-31 R$7.35 Billion
≈ $1.44 Billion
+13.73%
2017-12-31 R$6.46 Billion
≈ $1.27 Billion
+14.22%
2016-12-31 R$5.66 Billion
≈ $1.11 Billion
+20.43%
2015-12-31 R$4.70 Billion
≈ $922.07 Million
+16.05%
2014-12-31 R$4.05 Billion
≈ $794.54 Million
+12.04%
2013-12-31 R$3.61 Billion
≈ $709.15 Million
+8.20%
2012-12-31 R$3.34 Billion
≈ $655.40 Million
+5.42%
2011-12-31 R$3.17 Billion
≈ $621.68 Million
+243.53%
2010-12-31 R$922.28 Million
≈ $180.97 Million
+26.18%
2009-12-31 R$730.95 Million
≈ $143.43 Million
+22.61%
2008-12-31 R$596.18 Million
≈ $116.98 Million
+5.06%
2007-12-31 R$567.46 Million
≈ $111.35 Million
+89.73%
2006-12-31 R$299.10 Million
≈ $58.69 Million
+32.68%
2005-12-31 R$225.42 Million
≈ $44.23 Million
+15.67%
2004-12-31 R$194.89 Million
≈ $38.24 Million
+17.23%
2003-12-31 R$166.25 Million
≈ $32.62 Million
+8.29%
2002-12-31 R$153.53 Million
≈ $30.12 Million
+11.61%
2001-12-31 R$137.56 Million
≈ $26.99 Million
+2.23%
2000-12-31 R$134.55 Million
≈ $26.40 Million
--

About Raia Drogasil S.A

SA:RADL3 Brazil Pharmaceutical Retailers
Market Cap
$7.53 Billion
R$38.36 Billion BRL
Market Cap Rank
#2723 Global
#36 in Brazil
Share Price
R$21.94
Change (1 day)
+2.28%
52-Week Range
R$13.36 - R$27.00
All Time High
R$29.92
About

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.